×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:

1739 Total Publications

Arterial spin labeled MRI in prodromal Alzheimer’s disease: A multi-site study.
Wang, Z., Das, S. R., Xie, S. X., Arnold, S. E., Detre, J. A., & Wolk, D. A.
2013; Journal Neuroimage: Clinical; vol. 2; pp. 630-6; doi:10.1016/j.nicl.2013.04.014
Prevalence of Alzheimer’s pathologic endophenotypes in asymptomatic and mildly impaired first-degree relatives.
Lampert, E. J., Roy Choudhury, K., Hostage, C. a, Petrella, J. R., & Doraiswamy, P. M.
2013; Journal PloS One; vol. 8; no. 4; pp. e60747; doi:10.1371/journal.pone.0060747
Prevalence of Alzheimer’s pathologic endophenotypes in asymptomatic and mildly impaired first-degree relatives.
Lampert, E. J., Roy Choudhury, K., Hostage, C. a, Petrella, J. R., & Doraiswamy, P. M.
2013; Journal PloS One; vol. 8; no. 4; pp. e60747; doi:10.1371/journal.pone.0060747
Cortical Thickness and Semantic Fluency in Alzheimer's Disease and Mild Cognitive Impairment
Eastman, J. A., Hwang, K. S., Lazaris, A., Chow, N., Ramirez, L., Babakchanian, S., … Apostolova, L. G.
PMID: 25346870 ; PMCID:4207059 ; 2013; Journal American Journal of Alzheimer's Disease; vol. 1; no. 2; pp. 81-92; doi:10.7726/ajad.2013.1006
Mixed-effects beta regression for modeling continuous bounded outcome scores using NONMEM when data are not on the boundaries.
Xu, X. S., Samtani, M. N., Dunne, A., Nandy, P., Vermeulen, A., & De Ridder, F.
PMID: 23645382 ; 2013; Journal Journal of Pharmacokinetics and Pharmacodynamics; vol. 40; pp. 537-544; doi:10.1007/s10928-013-9318-0
Targeted Recruitment Using Cerebrospinal Fluid Biomarkers: Implications for Alzheimer’s Disease Therapeutic Trials
Barnes, J., Bartlett, J. W., Fox, N. C., & Schott, J. M.
PMID: 23229078 ; 2013; Journal Journal of Alzheimer's Disease; vol. 34; no. 2; pp. 431-437; doi:10.3233/JAD-121936
Neuroimaging predictors of brain amyloidosis in mild cognitive impairment.
Tosun, D., Joshi, S., & Weiner, M. W.
2013; Journal Annals of Neurology; vol. 74; no. 2; pp. 188-98; doi:10.1002/ana.23921
Functional activity maps based on significance measures and Independent Component Analysis.
Martínez-Murcia, F. J., Górriz, J. M., Ramírez, J., Puntonet, C. G., & Illán, I. a.
2013; Journal Computer Methods and Programs in Biomedicine; vol. 111; no. 1; pp. 255-68; doi:10.1016/j.cmpb.2013.03.015
BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer’s Disease.
Gaser, C., Franke, K., Klöppel, S., Koutsouleris, N., & Sauer, H.
2013; Journal PloS One; vol. 8; no. 6; pp. e67346; doi:10.1371/journal.pone.0067346
CSF alpha-synuclein improves diagnostic and prognostic performance of CSF tau and Abeta in Alzheimer’s disease.
Toledo, J. B., Korff, A., Shaw, L. M., Trojanowski, J. Q., & Zhang, J.
2013; Journal Acta Neuropathologica; vol. 126; no. 5; pp. 683-697; doi:10.1007/s00401-013-1148-z